This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Syndax Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Serap Sankoh
Introduction
Serap Sankoh is a notable inventor based in Waltham, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and patent work. Her expertise lies in the selection of patients for combination therapies, particularly in the context of HDAC inhibitors.
Latest Patents
Serap Sankoh holds a patent titled "Selection of patients for combination therapy." This patent describes methods for selecting cancer patients for treatment with a combination therapy that includes an HDAC inhibitor and a second therapeutic agent. The methods provided focus on examining a non-cancer cell type that is CD14-positive, HLA-DR-high, and/or CD16-negative, serving as a therapeutic indicator in the setting of HDAC inhibitor combination therapies. She has 1 patent to her name.
Career Highlights
Serap is currently employed at Syndax Pharmaceuticals, Inc., where she continues to advance her research in cancer therapies. Her work is pivotal in developing more effective treatment strategies for cancer patients, enhancing the precision of therapeutic interventions.
Collaborations
Serap has collaborated with esteemed colleagues such as Peter Ordentlich and Lei Wang, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Serap Sankoh's contributions to cancer treatment through her patent and work at Syndax Pharmaceuticals, Inc. highlight her role as an influential inventor in the medical field. Her innovative methods for patient selection in combination therapies are paving the way for more effective cancer treatments.